Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Valneva SE as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −1 vs. Q3 2022
- Shares held
- 403.5K
- −30.7K (−7.1%) vs. Q3 2022
- Total value
- $5.16M
- +$797.1K (+18.3%) vs. Q3 2022
- New holders
- 0
- 2 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VALN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $19.8M |
| Q1 2026 | 21 | $24.4M |
| Q4 2025 | 19 | $45.8M |
| Q3 2025 | 18 | $64.3M |
| Q2 2025 | 18 | $25.6M |
| Q1 2025 | 14 | $4.53M |
| Q4 2024 | 12 | $3.16M |
| Q3 2024 | 10 | $4.35M |
| Q2 2024 | 11 | $4.73M |
| Q1 2024 | 11 | $3.60M |
| Q4 2023 | 9 | $3.98M |
| Q3 2023 | 10 | $4.69M |
| Q2 2023 | 11 | $5.55M |
| Q1 2023 | 11 | $4.27M |
| Q4 2022 | 10 | $5.16M |
| Q3 2022 | 11 | $4.36M |
| Q2 2022 | 9 | $1.40M |
| Q1 2022 | 11 | $4.70M |
| Q4 2021 | 10 | $6.43M |
| Q3 2021 | 8 | $8.27M |
| Q2 2021 | 9 | $21.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Valneva SE; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| General American Investors Co Inc | 345,000 | $4.42M | 0.43% | −30,000−8.0% | Reduced |
| Laurion Capital Management LP | 25,000 | $320.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 25,000 | $318.0K | 0.00% | −1,273−4.8% | Reduced |
| Morgan Stanley | 4,967 | $63.2K | 0.00% | −296−5.6% | Reduced |
| Barclays PLC | 1,682 | $21.4K | 0.00% | +1,233+274.6% | Added |
| Advisor Group Holdings, Inc. | 1,450 | $19.0K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 200 | $2.54K | 0.00% | 00.0% | Unchanged |
| AlphaMark Advisors, LLC | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 20 | $0 | 0.00% | −2−9.1% | Reduced |
| Ronald Blue Trust, Inc. | 40 | $0 | 0.00% | +30+300.0% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −386−100.0% | Sold out |